Issue 91, 2023

ATP-responsive Mn(ii)-based T1 contrast agent for MRI

Abstract

A novel diacetylpyridylcarbohydrazide–DAPyCOHz-based manganese(II) chelate with dipicolylamine/zinc(II) (DPA/Zn2+) arms (MnLDPA-Zn2) was developed for adenosine triphosphate (ATP) responsive magnetic resonance imaging (MRI) T1 contrast applications. Compound 2 shows enhanced relaxivity (r1 = 11.52 mM−1 s−1) upon selective ATP binding over other phosphates.

Graphical abstract: ATP-responsive Mn(ii)-based T1 contrast agent for MRI

Supplementary files

Article information

Article type
Communication
Submitted
17 Jul 2023
Accepted
19 Sep 2023
First published
19 Sep 2023
This article is Open Access
Creative Commons BY license

Chem. Commun., 2023,59, 13623-13626

ATP-responsive Mn(II)-based T1 contrast agent for MRI

S. Anbu, L. Kenning and G. J. Stasiuk, Chem. Commun., 2023, 59, 13623 DOI: 10.1039/D3CC03430E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements